ANGIOAI+
First Extension - Granted
Status timeline
- 26 Aug 2024Application filedNew Application Entered
- 5 Mar 2025Assigned to an examining attorneyAssigned To Examiner
- 5 Mar 2025Office action issuedNon-Final Action Written
- 29 May 2025Response to office action filedTeas Response To Office Action Received
- 30 May 2025Approved for publicationApproved For Pub - Principal Register
- 1 Jul 2025Published for oppositionPublished For Opposition
- 26 Aug 2025Notice of allowance issued — statement of use requiredNoa E-Mailed - Sou Required From Applicant
- 23 Feb 2026Statement-of-use extension 1 grantedSou Extension 1 Granted
All 18 USPTO events
| 2026-02-23 | Sou Teas Extension Received |
| 2026-02-23 | Sou Extension 1 Filed |
| 2026-02-23 | Sou Extension 1 Granted |
| 2026-02-23 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-08-26 | Noa E-Mailed - Sou Required From Applicant |
| 2025-07-01 | Published For Opposition |
| 2025-07-01 | Official Gazette Publication Confirmation E-Mailed |
| 2025-06-25 | Notification Of Notice Of Publication E-Mailed |
| 2025-05-30 | Approved For Pub - Principal Register |
| 2025-05-29 | Teas Response To Office Action Received |
| 2025-05-29 | Correspondence Received In Law Office |
| 2025-05-29 | Teas/Email Correspondence Entered |
| 2025-03-05 | New Application Office Supplied Data Entered |
| 2025-03-05 | Assigned To Examiner |
| 2025-03-05 | Non-Final Action Written |
| 2025-03-05 | Non-Final Action E-Mailed |
| 2025-03-05 | Notification Of Non-Final Action E-Mailed |
| 2024-08-26 | New Application Entered |
Goods & services
Class 9 Software, electronics & scientific
Downloadable and recorded software for obtaining cardiovascular and vessel imaging data and sensor data for use in medical patient diagnosis and treatment; Downloadable and recorded software for analyzing cardiovascular and vessel imaging data and sensor data for use in medical patient diagnosis and treatment; Downloadable and recorded software for analyzing, diagnosing, and treating cardiovascular and vascular diseases, illnesses, and conditions; Downloadable and recorded software for determining fractional flow reserve, flow rate, flow resistance and other parameters in and associated with vasculature; Downloadable and recorded software for determining the presence and/or severity of plaqu…
Class 10 Medical apparatus
Medical apparatus in the nature of medical sensors, fiducial markers for use in sensing and imaging, and imaging devices for obtaining and analyzing cardiovascular and vessel imaging data and sensor data for use in medical patient diagnosis and treatment; Medical apparatus for analyzing, diagnosing, and treating cardiovascular and vascular diseases, illnesses, and conditions; medical apparatus for measuring fractional flow reserve, flow rate, flow resistance and other parameters in and associated with vasculature; Medical apparatus for determining the presence and/or severity of plaque and stenoses; Medical apparatus in the nature of medical sensors, fiducial markers for use in sensing and i…
Class 42 Technology & SaaS
Software as a service (SAAS) services featuring software for use in analyzing, diagnosing, and treating cardiovascular and vascular diseases, illnesses and conditions; Software as a service (SAAS) services featuring software for determining fractional flow reserve, flow rate, flow resistance and other parameters in and associated with vasculature; Software as a service (SAAS) services featuring software for determining the presence and/or severity of plaque and stenoses; Software as a service (SAAS) services featuring software for obtaining cardiovascular and vessel imaging data and sensor data for use in medical patient diagnosis and treatment; Software as a service (SAAS) services featurin…
Source & freshness
Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 24 Feb 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.